Compounding Pharmacies Market To Surpass USD 14.3 Billion By 2026 At A CAGR Of 6.2%
Acumen Research and Consulting has announced the addition of the “Compounding Pharmacies Market” report to their offering.
The Compounding Pharmacies Market Industry Report 2030 is an in depth study analyzing the current state of the Compounding Pharmacies Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Compounding Pharmacies Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Compounding Pharmacies Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/1738
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Key players operating in the compounding pharmacies market are B. Braun Melsungen AG Company, Cantrell Drug Company, Dougherty’s Pharmacy, Fagron, Fresenius Kabi AG., Mcguff compounding pharmacy services, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, PharMEDium Services LLC, Triangle Lorraine’s Pharmacy, Village compounding Pharmacies, Wedgewood Village Pharmacy, and Rx3 Compounding Pharmacy. Mergers and acquisitions are some of the key strategies being adopted by the market players to enhance their share in the global market.
Market Segmentation:
Market By Product
- Oral
- Parenteral
- Rectal
- Topical
- Ophthalmic
- Others
By Therapeutic Area
- Pain Management
- Hormone Replacement Therapies
- Dermatological Applications
- Nutritional Supplement
- Others
By Sterility
- Non-sterile
- Sterile
Table Of Contents:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Compounding Pharmacies
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Compounding Pharmacies Market By Product
1.2.2.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Compounding Pharmacies Market Revenue Share By Product in 2018
1.2.2.3. Oral
1.2.2.4. Parenteral
1.2.2.5. Rectal
1.2.2.6. Topical
1.2.2.7. Ophthalmic
1.2.2.8. Others
1.2.3. Compounding Pharmacies Market By Therapeutic Area
1.2.3.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Therapeutic Area (2015-2026)
1.2.3.2. Pain Management
1.2.3.3. Hormone Replacement Therapies
1.2.3.4. Dermatological Applications
1.2.3.5. Nutritional Supplement
1.2.3.6. Others
1.2.4. Compounding Pharmacies Market By Sterility
1.2.4.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Sterility (2015-2026)
1.2.4.2. Non-sterile
1.2.4.3. Sterile
1.2.5. Compounding Pharmacies Market By Geography
1.2.5.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
1.2.5.3. Europe Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-Pacific Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin America Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA) Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Compounding Pharmacies Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Compounding Pharmacies Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Compounding Pharmacies Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Compounding Pharmacies Major Manufacturers in 2018
CHAPTER 4. COMPOUNDING PHARMACIES MARKET BY PRODUCT
4.1. Global Compounding Pharmacies Revenue By Product
4.2. Oral
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Parenteral
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Rectal
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Topical
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)\
4.6. Ophthalmic
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA
5.1. Global Compounding Pharmacies Revenue By Therapeutic Area
5.2. Pain Management
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Hormone Replacement Therapies
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Dermatological Applications
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Nutritional Supplement
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. COMPOUNDING PHARMACIES MARKET BY STERILITY
6.1. Global Compounding Pharmacies Revenue By Sterility
6.2. Non-sterile
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Sterile
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. NORTH AMERICA COMPOUNDING PHARMACIES MARKET BY COUNTRY
7.1. North America Compounding Pharmacies Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Compounding Pharmacies Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
CHAPTER 8. EUROPE COMPOUNDING PHARMACIES MARKET BY COUNTRY
8.1. Europe Compounding Pharmacies Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY COUNTRY
9.1. Asia-Pacific Compounding Pharmacies Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
CHAPTER 10. LATIN AMERICA COMPOUNDING PHARMACIES MARKET BY COUNTRY
10.1. Latin America Compounding Pharmacies Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA COMPOUNDING PHARMACIES MARKET BY COUNTRY
11.1. Middle East & Africa Compounding Pharmacies Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East & Africa Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By Sterility, 2015 – 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. B. Braun Melsungen AG Company
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Cantrell Drug Company
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Dougherty’s Pharmacy
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Fagron
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Fresenius Kabi AG.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Mcguff compounding pharmacy services
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Institutional Pharmacy Solutions
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. ITC Compounding Pharmacy
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. PharMEDium Services LLC
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
Ask Query Here: Richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/1738
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
